Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Celgene Corp. for $17.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Celgene Corp. (CELG)


Cash Flow Statement

Low level of difficulty

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Celgene Corp., consolidated cash flow statement

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net income hidden hidden hidden hidden hidden
Depreciation hidden hidden hidden hidden hidden
Amortization hidden hidden hidden hidden hidden
Impairment charges hidden hidden hidden hidden hidden
Deferred income taxes hidden hidden hidden hidden hidden
Change in value of contingent consideration and success payments hidden hidden hidden hidden hidden
Gain on sale of business hidden hidden hidden hidden hidden
Net (gain) loss on sales of debt securities available-for-sale and equity investments hidden hidden hidden hidden hidden
Fair value adjustments on equity investments hidden hidden hidden hidden hidden
Share-based compensation expense hidden hidden hidden hidden hidden
Share-based employee benefit plan expense hidden hidden hidden hidden hidden
Derivative instruments hidden hidden hidden hidden hidden
Other, net hidden hidden hidden hidden hidden
Accounts receivable hidden hidden hidden hidden hidden
Inventory hidden hidden hidden hidden hidden
Other operating assets hidden hidden hidden hidden hidden
Accounts payable and other operating liabilities hidden hidden hidden hidden hidden
Income tax payable hidden hidden hidden hidden hidden
Payment of contingent consideration hidden hidden hidden hidden hidden
Deferred revenue hidden hidden hidden hidden hidden
Change in current assets and liabilities, excluding the effect of acquisitions hidden hidden hidden hidden hidden
Adjustments to reconcile net income to net cash provided by operating activities hidden hidden hidden hidden hidden
Net cash provided by operating activities hidden hidden hidden hidden hidden
Proceeds from sales of debt securities available-for-sale hidden hidden hidden hidden hidden
Purchases of debt securities available-for-sale hidden hidden hidden hidden hidden
Capital expenditures hidden hidden hidden hidden hidden
Proceeds from sales of equity investment securities hidden hidden hidden hidden hidden
Purchases of equity investment securities hidden hidden hidden hidden hidden
Payments for acquisition of businesses, net of cash acquired hidden hidden hidden hidden hidden
Other investing activities hidden hidden hidden hidden hidden
Net cash used in investing activities hidden hidden hidden hidden hidden
Payment for treasury shares hidden hidden hidden hidden hidden
Proceeds from short-term borrowing hidden hidden hidden hidden hidden
Principal repayments on short-term borrowing hidden hidden hidden hidden hidden
Proceeds from the issuance of long-term debt hidden hidden hidden hidden hidden
Repayments of long-term debt hidden hidden hidden hidden hidden
Net proceeds (payments) from common equity put options hidden hidden hidden hidden hidden
Payment of contingent consideration hidden hidden hidden hidden hidden
Net proceeds from share-based compensation arrangements hidden hidden hidden hidden hidden
Excess tax benefit from share-based compensation arrangements hidden hidden hidden hidden hidden
Net cash provided by (used in) financing activities hidden hidden hidden hidden hidden
Effect of currency rate changes on cash and cash equivalents hidden hidden hidden hidden hidden
Net increase (decrease) in cash and cash equivalents hidden hidden hidden hidden hidden
Cash and cash equivalents at beginning of period hidden hidden hidden hidden hidden
Cash and cash equivalents at end of period hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Celgene Corp.’s net cash provided by operating activities increased from 2016 to 2017 but then slightly declined from 2017 to 2018.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Celgene Corp.’s net cash used in investing activities declined from 2016 to 2017 and from 2017 to 2018.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Celgene Corp.’s net cash provided by (used in) financing activities increased from 2016 to 2017 and from 2017 to 2018.